Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors

Fig. 3

Enthesitis Localization at Baseline and 6 (A, C) or 12 (B, D) Months. Patients had active enthesitis at baseline and received TNFi therapy. Data are presented for all TCs and for the subgroup of first TNFi TCs. P value corrected for multiplicity (using the Holm-Bonferroni method). TC, treatment course; TNFi, tumor necrosis factor inhibitor. *P<0.05, **P<0.01, and ***P<0.001

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us